Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hein

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
Pharmacogenetics and Genomics|January 29, 2025
Metabolic effects of heterocyclic amines on insulin‑induced AKT phosphorylation and gluconeogenic gene expression are modified by N -acetyltransferase 2 genetic polymorphismKennedy M Walls, Jonathan Y Joh, Madeline M Martinez, et al.
Journal of Cancer Research and Clinical Oncology|November 4, 2022
Upregulation of cytidine deaminase in NAT1 knockout breast cancer cellsKyung U Hong, Afi H Tagnedji, Mark A Doll, et al.
Carcinogenesis|November 25, 2011
Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA constructLori M Millner, Mark A Doll, Marcus W Stepp, et al.
Molecular Carcinogenesis|January 10, 2018
Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231Marcus W Stepp, Mark A Doll, Samantha M Carlisle, et al.
Scientific Reports|June 20, 2020
CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolismSamantha M Carlisle, Patrick J Trainor, Kyung U Hong, et al.
Diabetes|March 28, 2009
Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodelingYuehui Wang, Wenke Feng, Wanli Xue, et al.
Journal of Oncology|September 19, 2019
<i>N</i>-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell LinesMarcus W Stepp, Raúl A Salazar-González, Kyung U Hong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 9, 2007
Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissuesAnwar Husain, Xiaoyan Zhang, Mark A Doll, et al.
Cancer Detection and Prevention|June 29, 2002
Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predispositionAdrian J Fretland, Mark A Doll, Yuanqi Zhu, et al.
Toxicology and Applied Pharmacology|April 11, 2006
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblastsPayal Bhaiya, Sanjoy Roychowdhury, Piyush M Vyas, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Pharmacogenetics and Genomics|January 29, 2025
Metabolic effects of heterocyclic amines on insulin‑induced AKT phosphorylation and gluconeogenic gene expression are modified by N -acetyltransferase 2 genetic polymorphismKennedy M Walls, Jonathan Y Joh, Madeline M Martinez, et al.
Journal of Cancer Research and Clinical Oncology|November 4, 2022
Upregulation of cytidine deaminase in NAT1 knockout breast cancer cellsKyung U Hong, Afi H Tagnedji, Mark A Doll, et al.
Carcinogenesis|November 25, 2011
Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA constructLori M Millner, Mark A Doll, Marcus W Stepp, et al.
Molecular Carcinogenesis|January 10, 2018
Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231Marcus W Stepp, Mark A Doll, Samantha M Carlisle, et al.
Scientific Reports|June 20, 2020
CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolismSamantha M Carlisle, Patrick J Trainor, Kyung U Hong, et al.
Diabetes|March 28, 2009
Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodelingYuehui Wang, Wenke Feng, Wanli Xue, et al.
Journal of Oncology|September 19, 2019
<i>N</i>-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell LinesMarcus W Stepp, Raúl A Salazar-González, Kyung U Hong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 9, 2007
Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissuesAnwar Husain, Xiaoyan Zhang, Mark A Doll, et al.
Cancer Detection and Prevention|June 29, 2002
Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predispositionAdrian J Fretland, Mark A Doll, Yuanqi Zhu, et al.
Toxicology and Applied Pharmacology|April 11, 2006
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblastsPayal Bhaiya, Sanjoy Roychowdhury, Piyush M Vyas, et al.
Pageof 18